All In MedTech

FDA Clearance Tracker · P050044-S003

VITAGEL SURGICAL HEMOSTAT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 17, 2007 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 17, 2007

Approved

Time to decision

41 days

Received Nov 6, 2007. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P050044-S003
Device name
VITAGEL SURGICAL HEMOSTAT
Applicant
Stryker Corp.
Applicant location
Kalamazoo, MI
Received
Nov 6, 2007
Decided
Dec 17, 2007
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P050044

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A CONTRACT TESTING FACILITY LOCATED AT LEXAMED, TOLEDO, OHIO.

Source documents

Other decisions for Stryker Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.